Tnf Pharmaceuticals, Stock Performance
| TNFA Stock | 1.26 0.02 1.56% |
The entity has a beta of 0.29, which indicates not very significant fluctuations relative to the market. As returns on the market increase, TNF Pharmaceuticals,'s returns are expected to increase less than the market. However, during the bear market, the loss of holding TNF Pharmaceuticals, is expected to be smaller as well. At this point, TNF Pharmaceuticals, has a negative expected return of -0.16%. Please make sure to validate TNF Pharmaceuticals,'s treynor ratio, accumulation distribution, price action indicator, as well as the relationship between the potential upside and day median price , to decide if TNF Pharmaceuticals, performance from the past will be repeated at future time.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days TNF Pharmaceuticals, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical and fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
Last Split Factor 1:30 | Dividend Date 2019-11-25 | Last Split Date 2024-02-15 |
1 | TNFA Stock Plummets to 52-Week Low at 1.15 Amid Market Struggles - Investing.com Canada | 11/14/2024 |
2 | TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel SarcopeniaFrailty Treatment at Prestigious International Conference | 12/09/2024 |
3 | Unlocking Extensive Growth Opportunities of Breath Analyzer Market by 2031 Akers Biosciences Inc., Dragerwerk AG Co. | 01/10/2025 |
| Begin Period Cash Flow | 749.1 K |
TNF |
TNF Pharmaceuticals, Relative Risk vs. Return Landscape
If you would invest 161.00 in TNF Pharmaceuticals, on October 13, 2024 and sell it today you would lose (35.00) from holding TNF Pharmaceuticals, or give up 21.74% of portfolio value over 90 days. TNF Pharmaceuticals, is currently does not generate positive expected returns and assumes 6.7996% risk (volatility on return distribution) over the 90 days horizon. In different words, 60% of stocks are less volatile than TNF, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
TNF Pharmaceuticals, Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for TNF Pharmaceuticals,'s investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as TNF Pharmaceuticals,, and traders can use it to determine the average amount a TNF Pharmaceuticals,'s price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0241
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TNFA |
Estimated Market Risk
| 6.8 actual daily | 60 60% of assets are less volatile |
Expected Return
| -0.16 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average TNF Pharmaceuticals, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of TNF Pharmaceuticals, by adding TNF Pharmaceuticals, to a well-diversified portfolio.
TNF Pharmaceuticals, Fundamentals Growth
TNF Stock prices reflect investors' perceptions of the future prospects and financial health of TNF Pharmaceuticals,, and TNF Pharmaceuticals, fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on TNF Stock performance.
| Return On Equity | -2.98 | ||||
| Return On Asset | -0.32 | ||||
| Current Valuation | (9.48 M) | ||||
| Shares Outstanding | 2.37 M | ||||
| Price To Book | 0.44 X | ||||
| EBITDA | (4 M) | ||||
| Net Income | (4 M) | ||||
| Total Debt | 48.87 K | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (12.98 M) | ||||
| Earnings Per Share | (10.48) X | ||||
| Market Capitalization | 3.13 M | ||||
| Total Asset | 17.86 M | ||||
| Retained Earnings | (101.98 M) | ||||
| Working Capital | 828.25 K | ||||
About TNF Pharmaceuticals, Performance
By analyzing TNF Pharmaceuticals,'s fundamental ratios, stakeholders can gain valuable insights into TNF Pharmaceuticals,'s financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if TNF Pharmaceuticals, has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if TNF Pharmaceuticals, has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 112.47 | 161.01 | |
| Return On Tangible Assets | (0.49) | (0.51) | |
| Return On Capital Employed | (1.53) | (1.45) | |
| Return On Assets | (0.20) | (0.21) | |
| Return On Equity | (0.36) | (0.38) |
Things to note about TNF Pharmaceuticals, performance evaluation
Checking the ongoing alerts about TNF Pharmaceuticals, for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for TNF Pharmaceuticals, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| TNF Pharmaceuticals, generated a negative expected return over the last 90 days | |
| TNF Pharmaceuticals, has high historical volatility and very poor performance | |
| TNF Pharmaceuticals, may become a speculative penny stock | |
| TNF Pharmaceuticals, was previously known as MYMD Old and was traded on NASDAQ Exchange under the symbol MYMD. | |
| Net Loss for the year was (4 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| TNF Pharmaceuticals, generates negative cash flow from operations | |
| TNF Pharmaceuticals, has a poor financial position based on the latest SEC disclosures | |
| Latest headline from kalkinemedia.com: Unlocking Extensive Growth Opportunities of Breath Analyzer Market by 2031 Akers Biosciences Inc., Dragerwerk AG Co. |
- Analyzing TNF Pharmaceuticals,'s financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether TNF Pharmaceuticals,'s stock is overvalued or undervalued compared to its peers.
- Examining TNF Pharmaceuticals,'s industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating TNF Pharmaceuticals,'s management team can have a significant impact on its success or failure. Reviewing the track record and experience of TNF Pharmaceuticals,'s management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of TNF Pharmaceuticals,'s stock. These opinions can provide insight into TNF Pharmaceuticals,'s potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for TNF Stock analysis
When running TNF Pharmaceuticals,'s price analysis, check to measure TNF Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TNF Pharmaceuticals, is operating at the current time. Most of TNF Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of TNF Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TNF Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of TNF Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |